PHYSACTO explored the effects of bronchodilator therapy and exercise training, when added to a behavioral modification program, on exercise capacity and physical activity levels in patients with COPD.
This was an exploratory, randomized, partially double-blinded, placebo-controlled, phase IIIb, parallel group, multicenter and multinational clinical trial where 304 patients were randomized for 12 weeks in 4 different treatment groups.
Patients were using McRoberts DynaPort MoveMonitor 3 times for one week in the trial for activity assessment.
Study objectives include evaluating the amount of physical activity as measured with the activity monitor.
Study endpoints include: